Advertisement

Topics

Altus Capital Partners, Inc. Company Profile

00:50 EDT 20th August 2018 | BioPortfolio

Altus Capital Partners is a private equity firm that makes control investments in middle market manufacturing businesses. We believe that our exclusive focus on manufacturing provides us with a unique understanding of the opportunities and challenges faced by companies in the sector. We utilize a patient, thoughtful investment approach and seek to partner with the management teams of our operating companies to achieve growth. With offices in Wilton, CT and Lincolnshire, IL, Altus Capital Partners has completed 17 platform investments and numerous accretive add on acquisitions since 2003. For more information, please visit www.altuscapitalpartners.com/.


News Articles [1357 Associated News Articles listed on BioPortfolio]

Recipharm, Altus Enter Agreement

To further develop Altus’ patented INTELLITAB™ and FLEXITAB™ drug delivery technologies

Altus Formulation Inc.: Recipharm Signs Licensing Agreement with Altus Formulation

MONTREAL, QC / ACCESSWIRE / March 5, 2018 / Recipharm, the contract development and manufacturing organisation (CDMO), has signed a licensing agreement with Altus Formulation Inc., a Canadian drug ...

No chewing, grinding or snorting: Recipharm adds Altus anti-abuse tech

A license agreement will allow Recipharm to offer its customers Altus Formulationâs INTELLITAB and FLEXITAB anti-abuse drug delivery technologies.

CRMs for Highly Sensitive Instruments Need Ultrapure Water

ADEPT Pure Water, the specialists in water purification equipment, has supplied a centralised laboratory system to Certified Reference Materials (CRMs) provider Altus Science. Runcorn based Altus...

Aleph Capital and Crestview Partners Agree to €260M Equity Funding Commitment in DARAG to ...

LONDON and NEW YORK, July 30, 2018 /PRNewswire/ -- Aleph Capital Partners LLP ("Aleph Capital") and Crestview Partners ("Crestview") have today announced that funds under Read more...

Medigene-Aktie: Rückzug von Leerverkäufer GSA Capital Partners hat an Dynamik gewonnen!

Martinsried (www.aktiencheck.de) - Leerverkäufer GSA Capital Partners LLP hat Netto-Leerverkaufsposition in Medigene-Aktien stark verringert: Die Leerverkäufer des Hedgefonds GSA Capital Partners L....

Medigene: Leerverkäufer GSA Capital Partners hat sich deutlich zurückgezogen

Martinsried (www.aktiencheck.de) - Leerverkäufer GSA Capital Partners LLP verringert Netto-Leerverkaufsposition in Medigene-Aktien signifikant: Die Leerverkäufer des Hedgefonds GSA Capital Partners....

CStone closes $260mm Series B round; largest in Chinese biopharm history

Immuno-oncology firm CStone Pharmaceuticals Co. Ltd. raised $260mm through its Series B round, the largest funding of its kind in Chinese biopharma history. GIC Private Ltd. led and was joined by new ...

PubMed Articles [350 Associated PubMed Articles listed on BioPortfolio]

Health and social care coordination for severe and persistent mental illness in Australia: a mixed methods evaluation of experiences with the Partners in Recovery Program.

Care coordination has been identified as a person-centred response to the difficulty in meeting the needs of people with severe and persistent mental illness and complex needs. This study evaluated th...

What is the association between social capital and diabetes mellitus? A systematic review.

Social capital has been included as an element that could influence the self-perception of health, mortality and mental diseases. We systematically reviewed papers that studied the influence of social...

Social Capital and Health Among Older Chinese Immigrants: a Cross-Sectional Analysis of a Sample in a Canadian Prairie City.

The objective of this study was to examine the relationship between social capital and health among Chinese immigrants. The sample included 101 older Chinese immigrants aged 60 to 96 who were recruite...

"Who'll do all these if I'm not around?": Bonding social capital and health and well-being of inpatients.

Although social capital influences health-related decisions and behavioural patterns in many developing countries, minimal attention has been paid to the nuances of its effect on healthcare. This pape...

Association Between Community Social Capital and Hospital Readmission Rates.

Hospital readmissions remain frequent, and are partly attributable to patients' social needs. The authors sought to examine whether local community levels of social capital are associated with hospita...

Clinical Trials [349 Associated Clinical Trials listed on BioPortfolio]

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Teachers and Parents as Partners During Middle School RCT

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

Companies [1880 Associated Companies listed on BioPortfolio]

Altus Capital Partners, Inc.

Altus Capital Partners is a private equity firm that makes control investments in middle market manufacturing businesses. We believe that our exclusive focus on manufacturing prov...

Altus Pharmaceuticals Inc.

Altus® Pharmaceuticals is focused on developing and commercializing novel protein therapeutics for patients with chronic gastrointestinal and metabolic diseases. Altus' in-depth knowledge of protein ...

Altus Biologics

Altus is a leading life sciences company, which has developed a unique, powerful and proprietary platform technology, known as Crystalomics™, to enable the rapid commercialization of high-value prot...

Altus Biologics Incorporated

Altus is a leading life sciences company, which has developed a unique, powerful and proprietary platform technology, known as Crystalomics™, to enable the rapid commercialization of high-value prot...

Oak Hill Capital Partners

Oak Hill Capital Partners is a private equity firm with more than $8.2 billion of committed capital from leading entrepreneurs, endowments, foundations, corporations, pension fund...

More Information about "Altus Capital Partners, Inc." on BioPortfolio

We have published hundreds of Altus Capital Partners, Inc. news stories on BioPortfolio along with dozens of Altus Capital Partners, Inc. Clinical Trials and PubMed Articles about Altus Capital Partners, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Altus Capital Partners, Inc. Companies in our database. You can also find out about relevant Altus Capital Partners, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...


Corporate Database Quicklinks



Searches Linking to this Company Record